Grand Pharmaceutical Group Limited is a diversified pharmaceutical company operating in the healthcare sector. Its primary function is the development, manufacture, and sale of medication and healthcare products. Known for its extensive portfolio, the company specializes in a wide range of products, including cardiovascular, anti-tumor, anti-infection, and diagnostic medicines. This robust lineup plays a crucial role in addressing some of the world's most common and challenging medical conditions.
In addition to pharmaceuticals, Grand Pharmaceutical Group Limited is involved in the production of healthcare-related consumer goods, reflecting the company's commitment to improving overall health and well-being. The firm operates on a global scale, supplying products to both domestic and international markets. This broad reach signifies its importance in the pharmaceutical industry, providing accessibility to essential medicines worldwide.
Grand Pharmaceutical Group Limited is seen as a vital player in the medical field, bringing innovation and trusted solutions to healthcare providers and patients. Its continuous research and development efforts underscore its role as a key contributor to medical advancements and healthcare efficiency.
Markedsdata leveret af TwelveData og Morningstar